REGN vs VG · P/E 14, rev $14.34B vs P/E 11, rev $13.77B
Regeneron Pharmaceuticals Inc (REGN) versus Venture Global, Inc. (VG) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Venture Global, Inc. (VG) is a oil & gas midstream company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported VG revenue for 2025-12-31 was $13.77B. Net income was $2.73B. Revenue was up 176.9% from 2024-12-31 to 2025-12-31. VG currently screens at market cap $26.69B and trailing P/E 11.2.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. VG currently screens at market cap $26.69B and trailing P/E 11.2.
Not investment advice. Open the REGN and VG stock pages for the full models.
Not investment advice.